CLINICAL MANIFESTATIONS IN RABBITS EXPERIMENTALLY INFECTED WITH ESCHERICHIA COLI O157:H7 ISOLATES OF DIFFERENT VIRULENCE GENE PROFILES

Authors

  • O. E. OJO Department of Veterinary Microbiology and Parasitology, College of Veterinary Medicine, Federal University of Agriculture, Abeokuta, Abeokuta. Postcode 110001. Nigeria
  • A. T.P. AJUWAPE Department of Veterinary Microbiology and Parasitology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria
  • O. L. AJAYI Department of Veterinary Pathology, College of Veterinary Medicine, Federal University of Agriculture Abeokuta, Abeokuta, Nigeria
  • E. B. OTESILE Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, Federal University of Agriculture Abeokuta, Abeokuta, Nigeria
  • A. I. ADETOSOYE Department of Veterinary Microbiology and Parasitology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria

DOI:

https://doi.org/10.51406/jnset.v11i2.1954

Keywords:

Clinical manifestation E. coli O157:H7, experimental infection, rabbits, virulence, gene profile

Abstract

Escherichia coli O157:H7 is a major cause of zoonotic food-borne infections transmissible from asymptomatic animals to humans following consumption of contaminated foods. Pathogenicity of E. coli O157:H7 is attributed to possession of virulence genes such as eaeA and stx responsible for intimate adhesion to enterocytes and production of cytolethal shiga toxins. The pathogenic potentials of five E. coli O157:H7 isolates of different virulence gene profiles recovered from the faeces of slaughter cattle was compared in rabbit model. Five groups (A-E) of five rabbits were each inoculated orally with 5 x 109 colony forming units of an E. coli O157:H7 isolate possessing one of the virulence gene profiles: stx1 / stx2 / eaeA / hlyA (group A), stx1 /stx2 (B), stx1 (C), stx2 (D), and eaeA / hlyA (E). Group F (control) received sterile broth. The mean onset and duration of clinical manifestations varied significantly among the experimental groups being earliest and shortest in group infected with E. coli O157:H7 possessing stx1 / stx2 /eaeA / hlyA. Infected rabbits showed clinical signs including dullness, profuse non-bloody diarrhoea, weakness, anorexia and epistaxis starting from two days post infection (p.i.). Epistaxis was observed only in rabbits inoculated with isolates that possessed stx2 either alone or in combination with other virulence genes. Mortality of 100% was recorded in isolates with stx1 /stx2 /eaeA / hlyA, stx1 / stx2 and stx2­ and 60% with stx1 and eaeA / hlyA.  Test organisms were detected in the faeces of inoculated animals as from two days p.i. and persisted in survivors for 19 to 30 days p.i. This study showed that E. coli O157:H7 isolates from cattle produced fatal illness in experimental rabbits and that virulence gene profile significantly influenced the onset, duration and severity of clinical manifestation of infection in the experimental animals.

 

 

 

References

Dean-Nystrom, E.A, Melton-Celsa, A.R., Pohlenz, J.F.L., Moon, H.W., O’Brien, A.D. 2003. Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 shiga toxin-producing E. coli strains in neonatal pigs. Infection and Immunity 71 (11): 6526 – 6533.

Dean-Nystrom, E.A., Stoffregen, W.C. Bosworth, B.T., Moon, H.W., Pohlenz, J.F. 2008. Early attachment sites for shiga-toxigenic Escherichia coli O157:H7 in experimentally inoculated weaned calves. Applied and Environmental Microbiology 78 (20): 6378 – 6384.

Gamage, S.D., Strasser, J.E., Chalk, C.L., Weiss, A.A. 2003. Nonpathogenic Escherichia coli can contribute to the production of shiga toxin. Infection and Immunity 71 (6): 3107 – 3115.

Garcia, A., Marini, R.P., Feng, Y., Vitsky, A., Knox, K.A., Taylor, N.S., Schauer, D.B., Fox, J.G. 2002. A naturally occurring rabbit model of enterohemorrhagic Escherichia coli-induced disease. The Journal of Infectious Diseases 186: 1682 – 1686.

Mead, P.S., Slutsker, L., Dietz, V., McCaig, L.F., Bresee, J.S., Shapiro, C., Griffin, P.M., Tauxe, R.V. 1999. Food-related illness and death in the United States. Emerging Infectious Diseases 5: 607 - 625.

Ojo, O.E., Ajuwape, A.T.P., Otesile, E.B., Owoade, A.A., Oyekunle, M.A., Adetosoye, A.I. 2010. Potentially zoonotic shiga toxin-producing Escherichia coli serogroups in the faeces and meat of food-producing animals in Ibadan, Nigeria. International Journal of Food Microbiology 142: 214 - 221.

Pai, C.H., Kelly, J.K. Meyers, G.L. 1986. Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infection and Immunity 51 (1): 16 – 23.

Paton, J.C., Paton, A.W., 1998. Pathogenesis and diagnosis of shiga toxin-producing Escherichia coli infections. Clinical Microbiology Reviews 11, 450-479.

Raji, M.A., Minga, U., Machangu, R. 2009. Day-old infant rabbit model for enterohaemorrhagic Escherichia coli induced diarrhoea. Veterinarski Arhiv 79 (2): 167-177.

Rangel, J.M., Sparling, P.H, Crowe, C., Griffin, P.M., Swerdlow, D.L. 2005. Epidemiology of Escherichia coli O157:H7 Outbreaks, United States, 1982–2002. Emerging Infectious Diseases 11: 603–609.

Riley, L.W., Remis, R.S., Helgerson, S.D., McGee, H.B., Wells, G.J., Davis, B.R., Herbert, R.J., Olcott, E.S., Johnson, L.M., Hargrett, N.T., Blake, P.A., Cohen, M.L. 1983. Haemorrhagic colitis associated with a rare Escherichia coli serotype. New England Journal of Medicine 308: 681–685.

Ritchie, J.M., Thorpe, C.M., Rogers, A.B., Waldor, M.K. 2003. Critical roles for stx2, eae and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infection and immunity 71 (12): 7129 – 7139.

Sherman, P., Soni, R, Karmali, M. 1988. Attaching and effacing adherence of verocytotoxin producing Escherichia coli to rabbit intestinal epithelium in vivo. Infection and Immunity 56 (4): 756-761.

Statistical Package for Social Sciences (SPSS) version 16 (2007). SPSS Inc. 233 South Wacker Drive, 11th floor Chicago, Illinois 60606. http://www.spss.com

Stoffregen, W.C., Pohlenz, J.F.L. Dean-Nystrom, E.A. 2004. Escherichia coli O157:H7 in the gall bladder of experimentally infected calves. Journal of Veterinary Diagnostic Investigations 16: 79 – 83.

Tarr, P.I., Gordon, C.A., Chandler, W.L. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. The Lancet 365: 1073 – 1086.

Tauxe, R.V. 1997. Emerging foodborne diseases: an evolving public health challenge. Emerging Infectious Diseases 3 (4): 425 – 434.

Twardon, J., Sobieszczańska, B., Gonet, A., Blaszkowska, M. 2005. Epidemiology of shiga-like toxin-producing Escherichia coli strains (STEC). Electronic Journal of Polish Agricultural Universities 8: 4

Wagner, P.L., Livny, J., Neely, M.N., Acheson, D.W.K., Freidman, D.I. Waldo M.K. 2002. Bacteriophage control of shiga toxin 1 production and release by Escherichia coli. Molecular Microbiology 44 (4): 957 – 970.

Wang, J.Y., Wang, S.S., Yin, P.Z. 2006. Haemolytic uraemic syndrome caused by a non-O157:H7 Escherichia coli strain in experimentally inoculated dogs. Journal of Medical Microbiology 55: 23 – 29.

Zschöck, M., Hamann, H.P., Kloppert, B., Wolter, W. 2000. Shiga toxin-producing Escherichia coli in faeces of healthy dairy cows, sheep, and goats, prevalence and virulent properties. Letters in Applied Microbiology 31: 203-208.

Downloads

Published

2014-02-04

Issue

Vol. 11 No. 2 (2012)

Section

Articles